SCHEMBL413327

SCHEMBL413327

O=C1CCCCN1c1ccc2ncsc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
POLB P06746 1/20 0.43
BRD9 Q9H8M2 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
CD38 P28907 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HKDC1 Q2TB90 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DYRK1A Q13627 2/20 0.40
DYRK2 Q92630 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL423755 0.96 ALDH1A1 (0.44) L3MBTL1SMN1; SMN2ALDH1A1HPGDPOLB
SCHEMBL409024 0.90 LMNA (0.44) L3MBTL1SMN1; SMN2ALDH1A1HPGDPOLB
SCHEMBL410434 0.78 L3MBTL1 (0.45) L3MBTL1SMN1; SMN2ALDH1A1HPGDPOLB
SCHEMBL26683994 0.77 CRBN (0.50) L3MBTL1POLBCYP3A4CYP2C9CYP2C19
SCHEMBL30688283 0.77 CRBN (0.50) L3MBTL1POLBCYP3A4CYP2C9CYP2C19
SCHEMBL410875 0.76 CYP3A4 (0.43) L3MBTL1SMN1; SMN2POLBCYP3A4CYP2C9
SCHEMBL21091414 0.74 GAA (0.57) L3MBTL1SMN1; SMN2ALDH1A1POLBCYP3A4
SCHEMBL414419 0.73 DYRK1A (0.42) L3MBTL1SMN1; SMN2ALDH1A1POLBCYP3A4
SCHEMBL3785123 0.71 DRD3 (0.44) L3MBTL1SMN1; SMN2ALDH1A1CYP3A4CYP2C9
SCHEMBL414418 0.70 LMNA (0.45) L3MBTL1SMN1; SMN2POLBCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408769-A1 PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS Glaxo Group Limited (GB) 2012-01-25 EP disclosed
WO-2010106016-A1 PYRIMIDINE DERIVATIVES USED AS ITK INHIBITORS GLAXO GROUP LIMITED (GB) 2010-09-23 WO disclosed